Drugs / [13C]-BMS-791325
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02112110 | Apr → May 2014 | hepatitis C virus infection | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [13C]-BMS-791325 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02112110 ↗ |
| Route | Intravenous | “[13C]-BMS-791325 single dose solution intravenously” NCT02112110 ↗ |